Pacira Pharmaceuticals Inc (PCRX)
Return on assets (ROA)
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | 41,955 | 15,909 | 41,980 | 145,523 | -11,016 |
| Total assets | US$ in thousands | 1,574,390 | 1,681,200 | 2,075,350 | 1,274,510 | 831,065 |
| ROA | 2.66% | 0.95% | 2.02% | 11.42% | -1.33% |
December 31, 2023 calculation
ROA = Net income ÷ Total assets
= $41,955K ÷ $1,574,390K
= 2.66%
Based on the provided data, Pacira BioSciences Inc's return on assets (ROA) has exhibited fluctuations over the past five years. In 2023, the ROA stands at 2.66%, showing an improvement compared to 2022 when it was 0.95%. This indicates that the company generated $2.66 in net income for every $100 of assets in 2023.
In 2021, the ROA was 2.02%, which was lower than the previous year of 11.42% in 2020. The significant drop in ROA from 2020 to 2021 suggests a decrease in the company's efficiency in generating profits from its assets during that period.
Furthermore, in 2019, Pacira BioSciences Inc experienced a negative ROA of -1.33%, indicating that the company incurred losses relative to its asset base in that year.
Overall, the improvement in ROA from 2022 to 2023 is a positive sign, but it is essential to monitor the trend in conjunction with other financial metrics to assess the company's operational efficiency and profitability in the long term.
Peer comparison
Dec 31, 2023